240 related articles for article (PubMed ID: 29243501)
1. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
[TBL] [Abstract][Full Text] [Related]
2. Micro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):267-274. PubMed ID: 28679327
[TBL] [Abstract][Full Text] [Related]
3. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.
Dierks RM; Bruyère O; Reginster JY; Richy FF
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):571-578. PubMed ID: 27653356
[TBL] [Abstract][Full Text] [Related]
4. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
7. Biopharma CRO industry in China: landscape and opportunities.
Xia C; Gautam A
Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical futures: made in China?
Cyranoski D
Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
[No Abstract] [Full Text] [Related]
9. Outsourcing lead optimization: the eye of the storm.
Clark DE
Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
[TBL] [Abstract][Full Text] [Related]
10. Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?
Littman BH; Marincola FM
J Transl Med; 2011 May; 9():56. PubMed ID: 21569250
[TBL] [Abstract][Full Text] [Related]
11. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
[TBL] [Abstract][Full Text] [Related]
12. Taking the pulse of strategic outsourcing relationships.
Getz KA; Lamberti MJ; Kaitin KI
Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
[TBL] [Abstract][Full Text] [Related]
13. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
Forster SP; Stegmaier J; Spycher R; Seeger S
Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
[TBL] [Abstract][Full Text] [Related]
14. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
15. UK industry consolidation is slow despite big merger.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
[No Abstract] [Full Text] [Related]
16. Outsourcing chemical synthesis in the drug discovery process.
Festel G
Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials in India.
Maiti R; M R
Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
[TBL] [Abstract][Full Text] [Related]
18. Outsourcing lead optimisation--the quiet revolution.
Clark DE; Newton CG
Drug Discov Today; 2004 Jun; 9(11):492-500. PubMed ID: 15149625
[TBL] [Abstract][Full Text] [Related]
19. The quiet revolution: outsourcing in pharma.
Crossley R
Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
[No Abstract] [Full Text] [Related]
20. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
[Next] [New Search]